Elevance Health, Inc. (ELV)

Elevance Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	5,360	5,980	5,987	5,894	6,158	4,572
Depreciation & Amortization	746	659	1,060	1,076	817	742
Other Amortization	734	734	685	599	485	412
Gain (Loss) on Sale of Assets	39	-201	-	-	-	-
Stock-Based Compensation	199	191	289	264	255	283
Change in Accounts Receivable	-3,439	-683	-1,762	-2,510	-2,138	-256
Change in Accounts Payable	1,118	-272	1,640	824	719	1,978
Change in Unearned Revenue	-140	-113	290	-42	-113	202
Change in Income Taxes	833	404	-103	-338	140	72
Change in Insurance Reserves / Liabilities	-87	-1,840	147	2,411	2,523	3,528
Change in Other Net Operating Assets	936	785	-747	78	-8	-270
Other Operating Activities	217	62	96	429	15	-722
Operating Cash Flow	6,454	5,808	8,061	8,399	8,364	10,688
Operating Cash Flow Growth	212.24%	-27.95%	-4.02%	0.42%	-21.74%	76.34%
Capital Expenditures	-1,117	-1,256	-1,296	-1,152	-1,087	-1,021
Cash Acquisitions	-3,631	-4,809	-1,552	-649	-3,476	-1,976
Investment in Securities	2,330	586	-2,700	-2,338	-4,056	-3,433
Other Investing Activities	-169	-51	-24	-421	-1,019	-894
Investing Cash Flow	-2,623	-5,167	-5,572	-4,560	-9,638	-7,324
Short-Term Debt Issued	-	275	339	2,298	2,331	2,305
Long-Term Debt Issued	-	7,710	2,574	3,373	3,462	2,484
Total Debt Issued	6,182	7,985	2,913	5,671	5,793	4,789
Total Debt Repaid	-3,274	-2,498	-2,251	-3,574	-2,494	-3,752
Net Debt Issued (Repaid)	2,908	5,487	662	2,097	3,299	1,037
Issuance of Common Stock	85	221	152	182	203	176
Repurchases of Common Stock	-3,178	-3,009	-2,775	-2,409	-2,002	-2,828
Common Dividends Paid	-1,522	-1,508	-1,395	-1,229	-1,104	-954
Other Financing Activities	-17	2	7	41	27	2
Financing Cash Flow	-1,724	1,193	-3,349	-1,318	423	-2,567
Foreign Exchange Rate Adjustments	1	-6	-1	-14	-10	7
Miscellaneous Cash Flow Adjustments	-45	-66	-	-	-	-
Net Cash Flow	2,063	1,762	-861	2,507	-861	804
Free Cash Flow	5,337	4,552	6,765	7,247	7,277	9,667
Free Cash Flow Growth	550.85%	-32.71%	-6.65%	-0.41%	-24.72%	93.96%
Free Cash Flow Margin	2.82%	2.57%	3.95%	4.63%	5.25%	7.93%
Free Cash Flow Per Share	23.28	19.55	28.50	29.85	29.48	38.01
Cash Interest Paid	1,239	1,239	1,032	878	822	794
Cash Income Tax Paid	1,303	1,303	1,936	1,594	1,299	1,790
Levered Free Cash Flow	12,048	6,846	3,005	8,425	3,614	6,741
Unlevered Free Cash Flow	12,876	7,586	3,649	8,960	4,115	7,232
Change in Working Capital	-779	-1,719	-535	423	1,123	5,254

Updated Jul 17, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.

SEC Filings: 10-K · 10-Q